
WuXi Beyond
药明博锐
WuXi Beyond
Biotech/Healthcare
WuXi Biori was jointly incubated in 2018 by WuXi AppTec and Peking University’s Suzhou-Nantong Institute of Molecular Engineering. Leveraging Peking University’s basic research, the company is building a next-generation platform for the R&D, manufacturing, and clinical application of targeted…
Latest round: Series A (2022)
Source: ChinaBulls — chinabulls.com
Last updated 2022-09-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.